Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
Der Nervenarzt|September 14, 1999
[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis]C Zimmermann, E U Walther, N Goebels, et al.
Revue Neurologique|September 9, 2005
[Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response]C Confavreux, S Vukusic, T Arbizu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1996
Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onsetR Gold, U Bogdahn, L Kappos, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 6, 2008
Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosisK Gugleta, M Mehling, A Kochkorov, et al.
Leukemia & Lymphoma|January 1, 1996
Fatal vascular leak syndrome with extensive hemorrhage, peripheral neuropathy and reactive erythrophagocytosis: an unusual complication of recombinant IL-3 therapyN Hurwitz, A Probst, G Zufferey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized studyC Polman, F Barkhof, L Kappos, et al.
Neurology|May 14, 2003
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1bM P Sormani, P Bruzzi, K Beckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2008
Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosisM M Ehrensperger, A Grether, G Romer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 26, 2017
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trialsA Traboulsee, Dkb Li, R Tam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trialC H Polman, F Dahlke, A J Thompson, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
Der Nervenarzt|September 14, 1999
[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis]C Zimmermann, E U Walther, N Goebels, et al.
Revue Neurologique|September 9, 2005
[Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response]C Confavreux, S Vukusic, T Arbizu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1996
Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onsetR Gold, U Bogdahn, L Kappos, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 6, 2008
Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosisK Gugleta, M Mehling, A Kochkorov, et al.
Leukemia & Lymphoma|January 1, 1996
Fatal vascular leak syndrome with extensive hemorrhage, peripheral neuropathy and reactive erythrophagocytosis: an unusual complication of recombinant IL-3 therapyN Hurwitz, A Probst, G Zufferey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized studyC Polman, F Barkhof, L Kappos, et al.
Neurology|May 14, 2003
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1bM P Sormani, P Bruzzi, K Beckmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2008
Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosisM M Ehrensperger, A Grether, G Romer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 26, 2017
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trialsA Traboulsee, Dkb Li, R Tam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trialC H Polman, F Dahlke, A J Thompson, et al.
Pageof 23